Author Info: (1) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2) Department of Genomic Medicine, The University of Texas MD Anderson Can

Author Info: (1) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (3) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (4) Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (5) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Houston, TX, USA. (6) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (7) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (8) Centre de Recherche des Cordeliers, Sorbonne Universit, INSERM, Universite Paris Cite, Equipe labellise Ligue Contre le Cancer, Paris, France. (9) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (10) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (11) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (12) Laura and Isaac Perlmutter Cancer Center, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. (13) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (14) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (15) Department of Biostatistics, The University of North Carolina, Chapel Hill, NC, USA. Department of Genetics, The University of North Carolina, Chapel Hill, NC, USA. (16) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (17) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (18) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (19) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (20) Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (21) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (22) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (23) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (24) Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (25) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (26) Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. (27) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (28) Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (29) Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (30) Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (31) Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Houston, TX, USA. (32) Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (33) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (34) Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (35) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Houston, TX, USA. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (36) Centre de Recherche des Cordeliers, Sorbonne Universit, INSERM, Universite Paris Cite, Equipe labellise Ligue Contre le Cancer, Paris, France. (37) Centre de Recherche des Cordeliers, Sorbonne Universit, INSERM, Universite Paris Cite, Equipe labellise Ligue Contre le Cancer, Paris, France. (38) Laura and Isaac Perlmutter Cancer Center, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA. (39) The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Houston, TX, USA. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA. (40) Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (41) Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (42) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Houston, TX, USA. James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Center for Cellular Language Intelligence, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
